Cidel Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Buy
8,666
+180
+2% +$23.7K 0.05% 161
2026
Q1
$1.18M Buy
8,486
+1,094
+15% +$153K 0.06% 139
2025
Q4
$907K Sell
7,392
-377
-5% -$45.8K 0.06% 144
2025
Q3
$862K Sell
7,769
-491
-6% -$55.8K 0.05% 135
2025
Q2
$916K Sell
8,260
-908
-10% -$96.6K 0.06% 134
2025
Q1
$1.03M Sell
9,168
-552
-6% -$57K 0.07% 114
2024
Q4
$898K Hold
9,720
0.06% 122
2024
Q3
$815K Buy
9,720
+175
+2% +$13.4K 0.06% 136
2024
Q2
$655K Buy
9,545
+634
+7% +$42.3K 0.05% 148
2024
Q1
$653K Buy
8,911
+412
+5% +$31.7K 0.05% 154
2023
Q4
$689K Buy
+8,499
New +$661K 0.03% 153
2022
Q1
Sell
-10,540
Closed -$765K 149
2021
Q4
$765K Hold
10,540
0.03% 91
2021
Q3
$736K Sell
10,540
-32
-0.3% -$2.25K 0.03% 86
2021
Q2
$728K Sell
10,572
-761
-7% -$50.8K 0.03% 88
2021
Q1
$732K Buy
11,333
+241
+2% +$15.5K 0.03% 87
2020
Q4
$646K Buy
11,092
+991
+10% +$59.8K 0.04% 77
2020
Q3
$638K Hold
10,101
0.04% 81
2020
Q2
$777K Buy
+10,101
New +$774K 0.04% 75

Other funds holding GILD

Cidel Asset Management's GILD Position: Q2 2026 in Review

Cidel Asset Management increased its Gilead Sciences (GILD) stake by 2.1% in Q2 2026, buying an estimated $23.7K and bringing the position to 8,666 shares worth $1.09M. The position accounts for 0.05% of the portfolio, ranked #161.

Cidel Asset Management first reported a position in GILD in Q2 2020 and has held it in 18 quarters since. The position peaked at $1.18M in Q1 2026. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Cidel Asset Management held 8,666 shares of Gilead Sciences worth $1.09M as of Q2 2026.
  • Cidel Asset Management bought 180 Gilead Sciences shares in Q2 2026, an estimated $23.7K.
  • Gilead Sciences made up 0.05% of Cidel Asset Management's portfolio in Q2 2026, its #161 holding.
  • Cidel Asset Management first reported a position in Gilead Sciences in Q2 2020 and has held it in 18 quarters since.
  • Cidel Asset Management's Gilead Sciences position peaked at $1.18M in Q1 2026.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cidel Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.